🚀 VC round data is live in beta, check it out!
Humanwell Healthcare Valuation Multiples
Discover revenue and EBITDA valuation multiples for Humanwell Healthcare and similar public comparables like GSK India, Amicus Therapeutics, Amneal Pharmaceuticals, Hanmi Pharm and more.
Humanwell Healthcare Overview
About Humanwell Healthcare
Humanwell Healthcare (Group) Co Ltd is a China-based integrated healthcare solution provider. It provides medicinal products including fertility-regulating drugs, Uyghur medicine, traditional Chinese medicine, medical devices, over-the-counter medicines, anti-infection drugs, herbal medicines, and biological products. The organization has a business presence in China and other international countries.
Founded
1993
HQ
Employees
17.6K
Website
Financials (FY)
EV
$5B
Humanwell Healthcare Financials
Humanwell Healthcare reported last fiscal year revenue of $4B and EBITDA of $639M.
In the same fiscal year, Humanwell Healthcare generated $2B in gross profit, $639M in EBITDA, and $272M in net income.
Revenue (LTM)
Humanwell Healthcare P&L
In the most recent fiscal year, Humanwell Healthcare reported revenue of $4B and EBITDA of $639M.
Humanwell Healthcare expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $4B | XXX | XXX | XXX |
| Gross Profit | — | XXX | $2B | XXX | XXX | XXX |
| Gross Margin | — | XXX | 48% | XXX | XXX | XXX |
| EBITDA | — | XXX | $639M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 18% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 16% | XXX | XXX | XXX |
| Net Profit | — | XXX | $272M | XXX | XXX | XXX |
| Net Margin | — | XXX | 8% | XXX | XXX | XXX |
| Net Debt | — | — | $635M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Humanwell Healthcare Stock Performance
Humanwell Healthcare has current market cap of $4B, and enterprise value of $5B.
Market Cap Evolution
Humanwell Healthcare's stock price is $2.76.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5B | $4B | -1.0% | XXX | XXX | XXX | $0.17 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialHumanwell Healthcare Valuation Multiples
Humanwell Healthcare trades at 1.4x EV/Revenue multiple, and 7.9x EV/EBITDA.
EV / Revenue (LTM)
Humanwell Healthcare Financial Valuation Multiples
As of April 18, 2026, Humanwell Healthcare has market cap of $4B and EV of $5B.
Equity research analysts estimate Humanwell Healthcare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Humanwell Healthcare has a P/E ratio of 16.5x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $4B | XXX | $4B | XXX | XXX | XXX |
| EV (current) | $5B | XXX | $5B | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 1.4x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 7.9x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 9.0x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 3.0x | XXX | XXX | XXX |
| P/E | — | XXX | 16.5x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 19.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Humanwell Healthcare Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Humanwell Healthcare Margins & Growth Rates
Humanwell Healthcare's revenue in the last fiscal year declined by (6%).
Humanwell Healthcare's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Humanwell Healthcare Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (6%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 18% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 15% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 14% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 2% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 6% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 32% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Humanwell Healthcare Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Humanwell Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| GSK India | XXX | XXX | XXX | XXX | XXX | XXX |
| Amicus Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Amneal Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| Hanmi Pharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Beijing Tiantan | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Humanwell Healthcare M&A Activity
Humanwell Healthcare acquired XXX companies to date.
Last acquisition by Humanwell Healthcare was on XXXXXXXX, XXXXX. Humanwell Healthcare acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Humanwell Healthcare
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialHumanwell Healthcare Investment Activity
Humanwell Healthcare invested in XXX companies to date.
Humanwell Healthcare made its latest investment on XXXXXXXX, XXXXX. Humanwell Healthcare invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Humanwell Healthcare
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Humanwell Healthcare
| When was Humanwell Healthcare founded? | Humanwell Healthcare was founded in 1993. |
| Where is Humanwell Healthcare headquartered? | Humanwell Healthcare is headquartered in China. |
| How many employees does Humanwell Healthcare have? | As of today, Humanwell Healthcare has over 17K employees. |
| Is Humanwell Healthcare publicly listed? | Yes, Humanwell Healthcare is a public company listed on Shanghai Stock Exchange. |
| What is the stock symbol of Humanwell Healthcare? | Humanwell Healthcare trades under 600079 ticker. |
| When did Humanwell Healthcare go public? | Humanwell Healthcare went public in 1997. |
| Who are competitors of Humanwell Healthcare? | Humanwell Healthcare main competitors are GSK India, Amicus Therapeutics, Amneal Pharmaceuticals, Hanmi Pharm. |
| What is the current market cap of Humanwell Healthcare? | Humanwell Healthcare's current market cap is $4B. |
| What is the current revenue of Humanwell Healthcare? | Humanwell Healthcare's last fiscal year revenue is $4B. |
| What is the current EV/Revenue multiple of Humanwell Healthcare? | Current revenue multiple of Humanwell Healthcare is 1.4x. |
| Is Humanwell Healthcare profitable? | No, Humanwell Healthcare is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.